BioSpace News Archive

Awards recognize Shimmer’s advances in developing wearable sensors tailored for specific uses, such as clinical trials and consumer neuroscience research

This combination targeted therapy may offer hope to infants diagnosed with a deadly type of leukemia

Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc., announced that the final study results from the Phase 3 APPROACH study evaluating WAYLIVRA® (volanesorsen) in patients with familial chylomicronemia syndrome (FCS) were published in the August 8th issue of The New England Journal of Medicine (NEJM).

CINCINNATI, August 7, 2019 - Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with Ology Bioservices, Inc.

AIDS Healthcare Foundation urged Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS drugs, to charge just $1.00 per pill for Descovy, the drug company’s fixed-dose combination of emtricitabine and tenofovir alafenamide, for its use as pre-exposure prophylaxis or PrEP to prevent HIV acquisition in uninfected individuals.

Platform for Functional Isolation of Invasive Circulating Tumor Cells Empowers Three LineaRx Product Categories: Diagnostics, Prognostics and Therapeutics; Creates Integrated Product and Service Offering

TCG leads funding round which will be used to expand its customer service capabilities and develop new technology

Karuna Therapeutics, Inc. announced financial results for the second quarter 2019 and provided a general business update.

OneOncology is Committed to Cost Conscious Healthcare for Patients & Payers

Initial results from a feasibility study conducted by Eli Lilly and Company, Evidation Health, and Apple Inc. showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device, in combination with digital apps may be able to differentiate people with mild cognitive impairment and mild Alzheimer’s disease dementia.